Transcriptional Control of Macrophage Identity, Self-Renewal, and Function

Advances in Immunology

Volumn 120, Issue , 2013, Pages 269-300

  Molawi, Kaaweh ^a,b,c,d   Sieweke, Michael H ^a,b,c,d  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Functional specialization; Macrophage identity; Macrophage polarization; Myeloid transcription factors; Myelopoiesis; Proliferation; Self renewal

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CHROMATIN; CHROMATIN MODIFICATION; ENVIRONMENT; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 84884371024     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-417028-5.00010-7     Document Type: Chapter

References (158)

1. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404(6774):193-197.
2. Ananieva O., Darragh J., Johansen C., Carr J.M., McIlrath J., Park J.M., et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nature Immunology 2008, 9(9):1028-1036.
3. Arinobu Y., Mizuno S., Chong Y., Shigematsu H., Iino T., Iwasaki H., et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007, 1(4):416-427.
4. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annual Review of Immunology 2009, 27:669-692.
5. Aziz A., Soucie E., Sarrazin S., Sieweke M.H. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009, 326(5954):867-871.
6. Aziz A., Vanhille L., Mohideen P., Kelly L.M., Otto C., Bakri Y., et al. Development of macrophages with altered actin organization in the absence of MafB. Molecular and Cellular Biology 2006, 26(18):6808-6818.
7. Bakri Y., Sarrazin S., Mayer U.P., Tillmanns S., Nerlov C., Boned A., et al. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005, 105(7):2707-2716.
8. Barish G.D., Yu R.T., Karunasiri M., Ocampo C.B., Dixon J., Benner C., et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes & Development 2010, 24(24):2760-2765.
9. Bhatt D.M., Pandya-Jones A., Tong A.J., Barozzi I., Lissner M.M., Natoli G., et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012, 150(2):279-290.
10. Calkhoven C.F., Muller C., Leutz A. Translational control of gene expression and disease. Trends in Molecular Medicine 2002, 8(12):577-583.
11. Carotta S., Dakic A., D'Amico A., Pang S.H., Greig K.T., Nutt S.L., et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 2010, 32(5):628-641.
12. Cartwright P., McLean C., Sheppard A., Rivett D., Jones K., Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005, 132(5):885-896.
13. Chen H., Ray-Gallet D., Zhang P., Hetherington C.J., Gonzalez D.A., Zhang D.E., et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 1995, 11(8):1549-1560.
14. Chen M.J., Yokomizo T., Zeigler B.M., Dzierzak E., Speck N.A. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457(7231):887-891.
15. Dahl R., Walsh J.C., Lancki D., Laslo P., Iyer S.R., Singh H., et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nature Immunology 2003, 4(10):1029-1036.
16. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99(1):111-120.
17. Dakic A., Metcalf D., Di Rago L., Mifsud S., Wu L., Nutt S.L. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. The Journal of Experimental Medicine 2005, 201(9):1487-1502.
18. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264(5164):1415-1421.
19. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000, 288(5470):1439-1441.
20. DeKoter R.P., Walsh J.C., Singh H. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. The EMBO Journal 1998, 17(15):4456-4468.
21. Escoubet-Lozach L., Benner C., Kaikkonen M.U., Lozach J., Heinz S., Spann N.J., et al. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genetics 2011, 7(12):e1002401.
22. Farnham P.J. Insights from genomic profiling of transcription factors. Nature Reviews. Genetics 2009, 10(9):605-616.
23. Feinberg M.W., Wara A.K., Cao Z., Lebedeva M.A., Rosenbauer F., Iwasaki H., et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. The EMBO Journal 2007, 26(18):4138-4148.
24. Feng R., Desbordes S.C., Xie H., Tillo E.S., Pixley F., Stanley E.R., et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(16):6057-6062.
25. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311(5757):83-87.
26. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447(7147):972-978.
27. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology 2012, 13(11):1118-1128.
28. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327(5966):656-661.
29. Gewirtz A.M., Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 1988, 242(4883):1303-1306.
30. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32(3):317-328.
31. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330(6005):841-845.
32. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature Reviews. Immunology 2010, 10(5):365-376.
33. Goenka S., Kaplan M.H. Transcriptional regulation by STAT6. Immunologic Research 2011, 50(1):87-96.
34. Gonda T.J., Buckmaster C., Ramsay R.G. Activation of c-myb by carboxy-terminal truncation: Relationship to transformation of murine haemopoietic cells in vitro. The EMBO Journal 1989, 8(6):1777-1783.
35. Gonda T.J., Ramsay R.G., Johnson G.R. Murine myeloid cell lines derived by in vitro infection with recombinant c-myb retroviruses express myb from rearranged vector proviruses. The EMBO Journal 1989, 8(6):1767-1775.
36. Gordon S., Martinez F.O. Alternative activation of macrophages: Mechanism and functions. Immunity 2010, 32(5):593-604.
37. Gorgoni B., Maritano D., Marthyn P., Righi M., Poli V. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. Journal of Immunology 2002, 168(8):4055-4062.
38. Goud T.J., Schotte C., van Furth R. Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. The Journal of Experimental Medicine 1975, 142(5):1180-1199.
39. Graf T. Myb: A transcriptional activator linking proliferation and differentiation in hematopoietic cells (Review). Current Opinion in Genetics & Development 1992, 2(2):249-255.
40. Growney J.D., Shigematsu H., Li Z., Lee B.H., Adelsperger J., Rowan R., et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005, 106(2):494-504.
41. Hambleton S., Salem S., Bustamante J., Bigley V., Boisson-Dupuis S., Azevedo J., et al. IRF8 mutations and human dendritic-cell immunodeficiency. The New England Journal of Medicine 2011, 365(2):127-138.
42. Hamers A.A., Vos M., Rassam F., Marinkovic G., Kurakula K., van Gorp P.J., et al. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circulation Research 2012, 110(3):428-438.
43. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nature Immunology 2011, 12(8):778-785.
44. Hanna R.N., Shaked I., Hubbeling H.G., Punt J.A., Wu R., Herrley E., et al. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circulation Research 2012, 110(3):416-427.
45. Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009, 138(1):129-145.
46. Hedge S.P., Kumar A., Kurschner C., Shapiro L.H. c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Molecular and Cellular Biology 1998, 18(5):2729-2737.
47. Hegde S.P., Zhao J., Ashmun R.A., Shapiro L.H. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood 1999, 94(5):1578-1589.
48. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459(7243):108-112.
49. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics 2007, 39(3):311-318.
50. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular Cell 2010, 38(4):576-589.
51. Herbert D.R., Holscher C., Mohrs M., Arendse B., Schwegmann A., Radwanska M., et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004, 20(5):623-635.
52. Himes S.R., Cronau S., Mulford C., Hume D.A. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages. Oncogene 2005, 24(34):5278-5286.
53. Hock H., Hamblen M.J., Rooke H.M., Traver D., Bronson R.T., Cameron S., et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003, 18(1):109-120.
54. Hoeffel G., Wang Y., Greter M., See P., Teo P., Malleret B., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. The Journal of Experimental Medicine 2012, 209(6):1167-1181.
55. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996, 87(2):307-317.
56. Hoogenkamp M., Krysinska H., Ingram R., Huang G., Barlow R., Clarke D., et al. The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis. Molecular and Cellular Biology 2007, 27(21):7425-7438.
57. Hoogenkamp M., Lichtinger M., Krysinska H., Lancrin C., Clarke D., Williamson A., et al. Early chromatin unfolding by RUNX1: A molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 2009, 114(2):299-309.
58. Huang G., Zhang P., Hirai H., Elf S., Yan X., Chen Z., et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nature Genetics 2008, 40(1):51-60.
59. Iwasaki H., Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007, 26(6):726-740.
60. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van Rooijen N., et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332(6035):1284-1288.
61. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nature Cell Biology 2008, 10(3):353-360.
62. Johansen L.M., Iwama A., Lodie T.A., Sasaki K., Felsher D.W., Golub T.R., et al. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Molecular and Cellular Biology 2001, 21(11):3789-3806.
63. Kataoka K., Fujiwara K.T., Noda M., Nishizawa M. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Molecular and Cellular Biology 1994, 14(11):7581-7591.
64. Kataoka K., Noda M., Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Molecular and Cellular Biology 1994, 14(1):700-712.
65. Kawasaki E.S., Ladner M.B., Wang A.M., Van Arsdell J., Warren M.K., Coyne M.Y., et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985, 230(4723):291-296.
66. Kelly L.M., Englmeier U., Lafon I., Sieweke M.H., Graf T. MafB is an inducer of monocytic differentiation. The EMBO Journal 2000, 19(9):1987-1997.
67. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nature Neuroscience 2013, 16(3):273-280.
68. Klappacher G.W., Lunyak V.V., Sykes D.B., Sawka-Verhelle D., Sage J., Brard G., et al. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 2002, 109(2):169-180.
69. Kohyama M., Ise W., Edelson B.T., Wilker P.R., Hildner K., Mejia C., et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009, 457(7227):318-321.
70. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 2011, 12(3):231-238.
71. Krysinska H., Hoogenkamp M., Ingram R., Wilson N., Tagoh H., Laslo P., et al. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene. Molecular and Cellular Biology 2007, 27(3):878-887.
72. Kurotaki D., Osato N., Nishiyama A., Yamamoto M., Ban T., Sato H., et al. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 2013, 121(10):1839-1849.
73. Laiosa C.V., Stadtfeld M., Xie H., de Andres-Aguayo L., Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006, 25(5):731-744.
74. Lancrin C., Sroczynska P., Stephenson C., Allen T., Kouskoff V., Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009, 457(7231):892-895.
75. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126(4):755-766.
76. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: Enabling diversity with identity. Nature Reviews. Immunology 2011, 11(11):750-761.
77. Leddin M., Perrod C., Hoogenkamp M., Ghani S., Assi S., Heinz S., et al. Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 2011, 117(10):2827-2838.
78. Liao X., Sharma N., Kapadia F., Zhou G., Lu Y., Hong H., et al. Kruppel-like factor 4 regulates macrophage polarization. The Journal of Clinical Investigation 2011, 121(7):2736-2749.
79. Lichtinger M., Ingram R., Hannah R., Muller D., Clarke D., Assi S.A., et al. RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. The EMBO Journal 2012, 31(22):4318-4333.
80. Lieu Y.K., Reddy E.P. Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle 2012, 11(18):3504-3512.
81. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320(5877):807-811.
82. Lord K.A., Abdollahi A., Hoffman-Liebermann B., Liebermann D.A. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Molecular and Cellular Biology 1993, 13(2):841-851.
83. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32(6):790-802.
84. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. The EMBO Journal 1996, 15(20):5647-5658.
85. Metchnikoff E. Lecture on phagocytosis and immunity. British Medical Journal 1891, 1(1570):213-217.
86. Miyamoto T., Iwasaki H., Reizis B., Ye M., Graf T., Weissman I.L., et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Developmental Cell 2002, 3(1):137-147.
87. Mossadegh-Keller N., Sarrazin S., Kandall P.K., Espinosa L., Standley R.E., Nutt S.L., et al. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 2013, 497(7448):239-243.
88. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nature Reviews. Immunology 2008, 8(12):958-969.
89. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991, 65(4):677-689.
90. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 2010, 33(1):12-24.
91. Natoli G., Ghisletti S., Barozzi I. The genomic landscapes of inflammation. Genes & Development 2011, 25(2):101-106.
92. Nerlov C., Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes & Development 1998, 12(15):2403-2412.
93. Nerlov C., Querfurth E., Kulessa H., Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000, 95(8):2543-2551.
94. Nguyen H.Q., Hoffman-Liebermann B., Liebermann D.A. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 1993, 72(2):197-209.
95. Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.W., et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468(7327):1119-1123.
96. North T.E., Stacy T., Matheny C.J., Speck N.A., de Bruijn M.F. Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells. Stem Cells 2004, 22(2):158-168.
97. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447(7148):1116-1120.
98. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84(2):321-330.
99. Okuno Y., Huang G., Rosenbauer F., Evans E.K., Radomska H.S., Iwasaki H., et al. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Molecular and Cellular Biology 2005, 25(7):2832-2845.
100. Ostuni R., Piccolo V., Barozzi I., Polletti S., Termanini A., Bonifacio S., et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152(1-2):157-171.
101. Park C., Li S., Cha E., Schindler C. Immune response in Stat2 knockout mice. Immunity 2000, 13(6):795-804.
102. Pello O.M., De Pizzol M., Mirolo M., Soucek L., Zammataro L., Amabile A., et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 2012, 119(2):411-421.
103. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: Complexity in action. Trends in Cell Biology 2004, 14(11):628-638.
104. Porse B.T., Bryder D., Theilgaard-Monch K., Hasemann M.S., Anderson K., Damgaard I., et al. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. The Journal of Experimental Medicine 2005, 202(1):85-96.
105. Putz G., Rosner A., Nuesslein I., Schmitz N., Buchholz F. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 2006, 25(6):929-939.
106. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138(1):114-128.
107. Ramirez-Carrozzi V.R., Nazarian A.A., Li C.C., Gore S.L., Sridharan R., Imbalzano A.N., et al. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes & Development 2006, 20(3):282-296.
108. Rekhtman N., Radparvar F., Evans T., Skoultchi A.I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: Functional antagonism in erythroid cells. Genes & Development 1999, 13(11):1398-1411.
109. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391(6662):79-82.
110. Rosenbauer F., Owens B.M., Yu L., Tumang J.R., Steidl U., Kutok J.L., et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nature Genetics 2006, 38(1):27-37.
111. Ross S.E., Radomska H.S., Wu B., Zhang P., Winnay J.N., Bajnok L., et al. Phosphorylation of C/EBPalpha inhibits granulopoiesis. Molecular and Cellular Biology 2004, 24(2):675-686.
112. Roussel M.F. Regulation of cell cycle entry and G1 progression by CSF-1. Molecular Reproduction and Development 1997, 46(1):11-18.
113. Roussel M.F., Davis J.N., Cleveland J.L., Ghysdael J., Hiebert S.W. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 1994, 9(2):405-415.
114. Rowland B.D., Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nature Reviews. Cancer 2006, 6(1):11-23.
115. Ruffell D., Mourkioti F., Gambardella A., Kirstetter P., Lopez R.G., Rosenthal N., et al. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(41):17475-17480.
116. Saha P., Geissmann F. Toward a functional characterization of blood monocytes. Immunology & Cell Biology 2011, 89(1):2-4.
117. Samokhvalov I.M., Samokhvalova N.I., Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 2007, 446(7139):1056-1061.
118. Sarrazin S., Mossadegh-Keller N., Fukao T., Aziz A., Mourcin F., Vanhille L., et al. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009, 138(2):300-313.
119. Sarrazin S., Sieweke M. Integration of cytokine and transcription factor signals in hematopoietic stem cell commitment. Seminars in Immunology 2011, 23(5):326-334.
120. Sasmono R.T., Oceandy D., Pollard J.W., Tong W., Pavli P., Wainwright B.J., et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101(3):1155-1163.
121. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology 2010, 11(10):936-944.
122. Scheller M., Foerster J., Heyworth C.M., Waring J.F., Lohler J., Gilmore G.L., et al. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 1999, 94(11):3764-3771.
123. Schiavoni G., Mattei F., Borghi P., Sestili P., Venditti M., Morse H.C., et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004, 103(6):2221-2228.
124. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336(6077):86-90.
125. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265(5178):1573-1577.
126. Sharf R., Meraro D., Azriel A., Thornton A.M., Ozato K., Petricoin E.F., et al. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. The Journal of Biological Chemistry 1997, 272(15):9785-9792.
127. Sica A., Mantovani A. Macrophage plasticity and polarization: In vivo veritas. The Journal of Clinical Investigation 2012, 122(3):787-795.
128. Sieweke M.H., Graf T. A transcription factor party during blood cell differentiation. Current Opinion in Genetics & Development 1998, 8(5):545-551.
129. Sieweke M.H., Tekotte H., Frampton J., Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 1996, 85(1):49-60.
130. Slomiany B.A., D'Arigo K.L., Kelly M.M., Kurtz D.T. C/EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Molecular and Cellular Biology 2000, 20(16):5986-5997.
131. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 2005, 435(7042):637-645.
132. Staber P.B., Zhang P., Ye M., Welner R.S., Nombela-Arrieta C., Bach C., et al. Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells. Molecular Cell 2013, 49(5):934-946.
133. Stopka T., Amanatullah D.F., Papetti M., Skoultchi A.I. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. The EMBO Journal 2005, 24(21):3712-3723.
134. Sullivan J., Feeley B., Guerra J., Boxer L.M. Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages. The Journal of Biological Chemistry 1997, 272(3):1943-1949.
135. Sumner R., Crawford A., Mucenski M., Frampton J. Initiation of adult myelopoiesis can occur in the absence of c-Myb whereas subsequent development is strictly dependent on the transcription factor. Oncogene 2000, 19(30):3335-3342.
136. Szanto A., Balint B.L., Nagy Z.S., Barta E., Dezso B., Pap A., et al. STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells. Immunity 2010, 33(5):699-712.
137. Tagliani E., Shi C., Nancy P., Tay C.S., Pamer E.G., Erlebacher A. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. The Journal of Experimental Medicine 2011, 208(9):1901-1916.
138. Tagoh H., Himes R., Clarke D., Leenen P.J., Riggs A.D., Hume D., et al. Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells. Genes & Development 2002, 16(13):1721-1737.
139. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., et al. Essential role of Stat6 in IL-4 signalling. Nature 1996, 380(6575):627-630.
140. Tamura T., Nagamura-Inoue T., Shmeltzer Z., Kuwata T., Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 2000, 13(2):155-165.
141. Tamura T., Thotakura P., Tanaka T.S., Ko M.S., Ozato K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 2005, 106(6):1938-1947.
142. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90(2):489-519.
143. Tillmanns S., Otto C., Jaffray E., Du Roure C., Bakri Y., Vanhille L., et al. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression. Molecular and Cellular Biology 2007, 27(15):5554-5564.
144. Valouev A., Johnson S.M., Boyd S.D., Smith C.L., Fire A.Z., Sidow A. Determinants of nucleosome organization in primary human cells. Nature 2011, 474(7352):516-520.
145. Walsh J.C., DeKoter R.P., Lee H.J., Smith E.D., Lancki D.W., Gurish M.F., et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 2002, 17(5):665-676.
146. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(8):3444-3449.
147. Xiao C., Rajewsky K. MicroRNA control in the immune system: Basic principles. Cell 2009, 136(1):26-36.
148. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117(5):663-676.
149. Yamamoto M., Kato T., Hotta C., Nishiyama A., Kurotaki D., Yoshinari M., et al. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One 2011, 6(10):e25812.
150. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007, 1(1):39-49.
151. Yanagisawa H., Nagasawa T., Kuramochi S., Abe T., Ikawa Y., Todokoro K. Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochimica et Biophysica Acta 1991, 1088(3):380-384.
152. Yeamans C., Wang D., Paz-Priel I., Torbett B.E., Tenen D.G., Friedman A.D. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 2007, 110(9):3136-3142.
153. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38(1):79-91.
154. Zhang D.E., Hetherington C.J., Chen H.M., Tenen D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Molecular and Cellular Biology 1994, 14(1):373-381.
155. Zhang D.E., Hetherington C.J., Meyers S., Rhoades K.L., Larson C.J., Chen H.M., et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Molecular and Cellular Biology 1996, 16(3):1231-1240.
156. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004, 21(6):853-863.
157. Zhang P., Zhang X., Iwama A., Yu C., Smith K.A., Mueller B.U., et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 2000, 96(8):2641-2648.
158. Zhao B., Takami M., Yamada A., Wang X., Koga T., Hu X., et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nature Medicine 2009, 15(9):1066-1071.